Jump Financial’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-12,316
Closed -$7.61K 2224
2024
Q2
$7.61K Buy
+12,316
New +$10.4K ﹤0.01% 1735
2023
Q2
Sell
-36,918
Closed -$103K 2255
2023
Q1
$103K Buy
36,918
+20,878
+130% +$59.7K ﹤0.01% 1436
2022
Q4
$55.3K Buy
+16,040
New +$45.8K ﹤0.01% 1492
2022
Q2
Sell
-42,400
Closed -$175K 2103
2022
Q1
$175K Buy
+42,400
New +$225K 0.01% 1333

Other funds holding GRTS

Jump Financial's GRTS Position: Q3 2024 in Review

Jump Financial sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 12,316 shares — an estimated $7.61K sold.

Jump Financial first reported a position in GRTS in Q1 2022 and held it in 4 quarters. The position peaked at $175K in Q1 2022. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.

  • Jump Financial reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Jump Financial sold 12,316 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $7.61K.
  • Jump Financial first reported a position in Gritstone bio, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Jump Financial's Gritstone bio, Inc. Common Stock position peaked at $175K in Q1 2022.
  • 56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.

Based on Jump Financial's 13F filing for Q3 2024, filed 14 Nov 2024.